For locally advanced cancers (stage 3), survival generally decreased with increasing age for females in age groups between 65 and 85 years and over from 91% to 68% at 3 years from diagnosis; and in age groups between 65 and 84 years from 89% to 67% at 5 years from diagnosis. For metastatic cancers (stage 4), relative survival generally decreased with increasing age for females across all age groups from 95% to 41% at 1 year from diagnosis; and in age groups between 40 and 79 years from 65% to 38% at 3 years from diagnosis. Relative survival varied among females in age groups between 45 and 74 years, ranging between 30% and 49% at 5 years from diagnosis.